The Wolverine Stack is the most popular healing peptide blend — BPC-157 (10mg) and TB-500 (10mg) pre-mixed in a single 20mg vial. BPC-157 drives localized repair (angiogenesis, growth factors), TB-500 handles the systemic side (cell migration, actin remodeling). For the full mechanism breakdown and synergy research, see the Wolverine Stack Benefits Guide.
Research-context information only. The Wolverine stack is a research-peptide blend (containing BPC-157 and TB-500). Protocols, doses, and reactions reported below come from published research and self-reported community sources. This article reports what has been documented, not what should be done. Consult a licensed physician for personal medical decisions.
Research compounds without FDA approval. All protocols below are community-derived. This is not medical advice.
Wolverine Stack (BPC-157 + TB-500) Dosing Table
Match your vial size below — reconstitution and dose math update automatically.
Vials are labeled "10/10" — 10 mg BPC-157 + 10 mg TB-500 (20 mg total). Doses split evenly between the two.
| Dose | Syringe units | mL volume | Schedule |
|---|---|---|---|
| 500 mcg blend | 5 units | 0.05 mL | Daily SubQStandard (250mcg of each) |
| 1 mg blend | 10 units | 0.1 mL | Daily SubQLoading (500mcg of each) |
Math assumes U-100 insulin syringes (1 mL = 100 units). Verify your syringe matches before injecting. Round half-units to the nearest visible mark.
Quick Reference: Community Protocol
| Parameter | Community Protocol |
|---|---|
| Dose | 500 mcg total daily (250 mcg each peptide) |
| Route | Subcutaneous injection |
| Timing | AM, before food |
| Frequency | Every day |
| Cycle | 8 weeks on, 8 weeks off |
| Vial size | 20 mg (10mg BPC-157 + 10mg TB-500) |
| Reconstitution | 2 mL bacteriostatic water → 10 mg/mL |
| Draw amount | 5 units on insulin syringe |
| Vials per cycle | 2 (each lasts 40 days) |
| Storage | Refrigerate, use within 28 days |
Community-reported standard protocol: 500 mcg total daily (5 units) in the morning for 8 weeks. For localized injuries, community protocols describe injecting near the target area, providing local BPC-157 concentration alongside systemic TB-500 coverage.
Cycling Details
The standard cycle is 8 weeks on, 8 weeks off (or 4 weeks off minimum). Healing effects continue during the off period as tissue remodeling processes complete. Community sources commonly describe continued improvement for 2–4 weeks after stopping.
Loading protocol (aggressive): 750 mcg/day for 4 weeks, then 500 mcg/day for 8 weeks = 12 weeks total. For chronic injuries that haven't responded to standard dosing.
Twice-daily acute protocol: 500 mcg AM + 500 mcg PM (1,000 mcg total/day) for 4 weeks, then standard 500 mcg/day. For first 4 weeks post-surgery or acute injuries where speed matters. Community sources describe twice-daily dosing as beneficial for acute protocols given BPC-157's short half-life.
Routes of Administration
Subcutaneous (standard): For localized injuries, community protocols describe injecting near the target area. For systemic recovery, rotate between standard sites (abdomen, thigh, upper arm). TB-500 works systemically regardless of site; BPC-157 achieves higher local concentrations when injected nearby.
Injection sites: Lower abdomen (2 inches from navel), front of thigh, back of upper arm. Community injection protocols describe rotating sites to minimize lipodystrophy risk.
Reconstitution Quick Reference
| BAC Water | Concentration | 500 mcg Dose | 750 mcg Dose | Days per Vial |
|---|---|---|---|---|
| 2 mL | 10 mg/mL | 5 units | 7.5 units | 40 days |
20 mg vial + 2 mL BAC water = 10 mg/mL (10,000 mcg/mL). A 500 mcg dose is 5 units on an insulin syringe.
Community protocols describe swirling gently rather than shaking to preserve peptide integrity, with refrigeration at 2-8°C and use within 28 days. For the full step-by-step walkthrough, see the Wolverine Stack Reconstitution Guide.
